AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
May 2, 2024
32559_dirs_2024-05-02_f27a1a5e-2867-4f4f-97ce-353f9c363b62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-05-01
Reporting Person: Jung Melita Sun (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-01 | Stock Option (Right to buy) | $5.08 | A | 475000.00 | Acquired | 2034-04-30 | Common Stock (475000.00) | Direct |
Footnotes
F1: 25% of the shares subject to the option vest on the first anniversary measured from May 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.